XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENT INFORMATION (Tables)
6 Months Ended
Apr. 30, 2022
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:
Three Months EndedSix Months Ended
 April 30,April 30,
 2022202120222021
 (in millions)
Net Revenue:
Life Sciences and Applied Markets$896 $881 $1,872 $1,804 
Diagnostics and Genomics358 315 697 609 
Agilent CrossLab353 329 712 660 
Total net revenue$1,607 $1,525 $3,281 $3,073 
Segment Income From Operations:
Life Sciences and Applied Markets$228 $226 $510 $491 
Diagnostics and Genomics91 69 159 124 
Agilent CrossLab87 69 178 145 
Total segment income from operations$406 $364 $847 $760 
The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets.  
 April 30,
2022
October 31,
2021
(in millions)
Segment Assets:  
Life Sciences and Applied Markets$3,788 $3,741 
Diagnostics and Genomics3,384 3,320 
Agilent CrossLab863 839 
Total segment assets$8,035 $7,900 
Reconciliation of segment results to total enterprise results
The following table reconciles segment income from operations to Agilent’s total enterprise income before taxes: 
Three Months EndedSix Months Ended
 April 30,April 30,
 2022202120222021
 (in millions)
Total segment income from operations$406 $364 $847 $760 
Transformational initiatives(9)(9)(13)(20)
Amortization of intangible assets related to business combinations(50)(46)(101)(90)
Acquisition and integration costs(8)(13)(15)(22)
Asset impairment— (2)— (2)
Change in fair value of contingent consideration28 — 25 — 
Business exit and divestiture costs(7)(3)(7)(4)
Other— (3)— (6)
Interest income
Interest expense(21)(20)(42)(39)
Other income (expense), net (1)
(7)(44)
Income before taxes, as reported$333 $273 $652 $585 

(1) For the three and six months ended April 30, 2022 and 2021, other income (expense), net includes net (gains) losses on the fair value of equity securities.